Wojcikiewicz R J, Nahorski S R
Department of Pharmacology and Therapeutics, University of Leicester, United Kingdom.
J Biol Chem. 1991 Nov 25;266(33):22234-41.
The possibility that chronic activation of the phosphoinositide-mediated signaling pathway modifies the Ca(2+)-mobilizing action of inositol 1,4,5-trisphosphate (InsP3) was examined. SH-SY5Y human neuroblastoma cells were exposed to carbachol, permeabilized electrically, loaded with 45Ca2+, and 45Ca2+ mobilization in response to exogenous InsP3 was assessed. In control permeabilized cells, InsP3 released 65 +/- 2% of sequestered 45Ca2+ (EC50 = 0.32 +/- 0.05 microM). Pre-treatment with carbachol reduced both maximal InsP3-induced 45Ca2+ release (to 34 +/- 3%, with half-maximal and maximal inhibition at approximately 3 and 6 h, respectively) and the potency of InsP3 (EC50 = 0.92 +/- 0.13 microM). This inhibitory effect of carbachol was half-maximal at approximately 5 microM, was mediated by muscarinic receptors, and was reversible following withdrawal of agonist. Pretreatment with phorbol 12,13-dibutyrate did not alter the maximal effect of InsP3 but doubled its EC50. Evidence suggesting that the inhibitory effects of carbachol pretreatment resulted from altered Ca2+ homeostasis was not forthcoming; both 45Ca2+ uptake and release induced by ionomycin and thapsigargin were identical in control and pretreated permeabilized cells, as were the characteristics of reuptake of released Ca2+. In contrast, carbachol pretreatment, without altering the affinity of InsP3 (Kd = 64 +/- 7 nM), reduced the density of [32P]InsP3-binding sites from 2.0 +/- 0.1 to 1.0 +/- 0.1 pmol/mg protein with a time course essentially identical to that for the reduction in responsiveness to InsP3. This effect was not mimicked by pretreatment of cells with phorbol 12,13-dibutyrate. These data indicate that chronic activation of phosphoinositide hydrolysis can reduce the abundance of InsP3 receptors and that this causes a reduction in size of the InsP3-sensitive Ca2+ store. This modification, possibly in conjunction with a protein kinase C-mediated event, appears to account for the carbachol-induced suppression of InsP3 action. As intracellular InsP3 mass remained elevated above basal for at least 24 h after addition of carbachol, suppression of the Ca(2+)-mobilizing activity of InsP3 represents an important adaptive response to cell stimulation that can limit the extent to which intracellular Ca2+ is mobilized.
研究了磷酸肌醇介导的信号通路慢性激活是否会改变肌醇1,4,5 -三磷酸(InsP3)的钙动员作用。将SH - SY5Y人神经母细胞瘤细胞暴露于卡巴胆碱,进行电通透处理,加载45Ca2+,并评估其对外源性InsP3的45Ca2+动员情况。在对照通透细胞中,InsP3释放了65±2%的螯合45Ca2+(半数有效浓度[EC50]=0.32±0.05微摩尔)。用卡巴胆碱预处理可降低InsP3诱导的最大45Ca2+释放量(降至34±3%,分别在约3小时和6小时出现半数最大抑制和最大抑制)以及InsP3的效力(EC50 = 0.92±0.13微摩尔)。卡巴胆碱的这种抑制作用在约5微摩尔时达到半数最大效应,由毒蕈碱受体介导,在去除激动剂后可逆。用佛波酯12,13 -二丁酸预处理不会改变InsP3的最大效应,但使其EC50增加一倍。没有证据表明卡巴胆碱预处理的抑制作用是由改变的钙稳态引起的;在对照和预处理的通透细胞中,离子霉素和毒胡萝卜素诱导的45Ca2+摄取和释放以及释放钙的再摄取特征均相同。相反,卡巴胆碱预处理在不改变InsP3亲和力(解离常数[Kd]=64±7纳摩尔)的情况下,将[32P]InsP3结合位点的密度从2.0±0.1皮摩尔/毫克蛋白降至1.0±0.1皮摩尔/毫克蛋白,其时间进程与对InsP3反应性降低的时间进程基本相同。用佛波酯12,13 -二丁酸预处理细胞不会模拟这种效应。这些数据表明,磷酸肌醇水解的慢性激活可降低InsP3受体的丰度,进而导致InsP3敏感钙库的大小减小。这种修饰可能与蛋白激酶C介导的事件共同作用,似乎可以解释卡巴胆碱诱导的InsP3作用的抑制。由于在添加卡巴胆碱后至少24小时内细胞内InsP3质量仍高于基础水平,因此抑制InsP3的钙动员活性代表了对细胞刺激的一种重要适应性反应,可限制细胞内钙动员的程度。